investordatabase.org

Aisling Capital Management LP

aislingcapital.com Direct investor

Aisling Capital is an investment firm that invests in healthcare products, technologies, and services. It manages over $1.8 billion in committed capital across multiple funds and invests in both private and public companies.

Aisling Capital Management LP is a venture capital firm headquartered in New York, United States, founded in 2000. It invests directly in companies, from seed to growth, in healthcare, biopharma, medical device and services. $1.8 billion under management, as it reports.

“Aisling Capital is a leading investment firm that invests in products, technologies, and global businesses that advance health.”

— Aisling Capital Management LP, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Growth
Headquarters
New York, United States
Invests in
US
Sectors
healthcare, biopharma, medical device, services
Founded
2000
Assets under management
$1.8 billion

Team, as Aisling Capital Management LP publishes it

  • Steven Elms Managing Partner
  • Andrew Schiff, MD Managing Partner
  • Eric Aguiar, MD Partner
  • Sunny Reddy Principal
  • Wonpyo Yun Principal
  • Robert Wenzel Chief Financial Officer and Chief Compliance Officer
  • Katie Tansey Vice President of Investor Relations and Marketing
  • Hannah Wieder Controller
  • Carol Zikopoulos Head of Human Resources and Compliance Manager
  • Dr. Josh Bilenker Operating Partner
  • Scott Braunstein, MD Operating Partner

Names and roles exactly as listed on aislingcapital.com. Nothing else about these people is recorded.

Most shared portfolio companies with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 71 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.

  • Foresite Capital 9 shared companies: ascendispharma.com, aclaristx.com, bicara.com, pfizer.com…
  • Hercules Adviser LLC 9 shared companies: bridgebio.com, agiletherapeutics.com, compasspathways.com, admabiologics.com…
  • EcoR1 Capital 8 shared companies: scholarrock.com, arcusbio.com, bridgebio.com, nabriva.com…
  • RA Capital Management 6 shared companies: ascendispharma.com, forgebiologics.com, aclaristx.com, bicara.com…
  • Frazier Life Sciences Management, LP 6 shared companies: veronapharma.com, bridgebio.com, chimerix.com, gondolabio.com…
  • Sofinnova Investments, INC. 5 shared companies: ascendispharma.com, obseva.com, aclaristx.com, audentestx.com…
  • F-Prime Capital 5 shared companies: allergan.com, aclaristx.com, bicara.com, sanofi.us…
  • Avoro Capital Advisors LLC 4 shared companies: ascendispharma.com, syndax.com, gbt.com, monterosatx.com
  • Sofinnova 4 shared companies: ascendispharma.com, f2g.com, obseva.com, veronapharma.com
  • ARCH Venture Partners 4 shared companies: scholarrock.com, syros.com, allergan.com, treeline.bio

and 61 more — the graph.

Where this comes from

Every fact above was read from a page Aisling Capital Management LP publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 5777 · added 2026-09-03 · link last verified 2026-10-21 · confidence high

Similar investors

  • Decheng Capital
    Venture capital · Seed – Growth · Menlo Park, United States
  • NGN Capital LLC
    Venture capital · Seed – Series B · New York, United States
  • 2048 Ventures
    Venture capital · Pre-seed – Seed · New York, United States
  • AlleyCorp
    Venture capital · Pre-seed – Series A · New York, United States
  • Alta Partners
    Venture capital · San Francisco, United States
  • ARC Capital Management
    Venture capital · Pre-seed – Seed · New York, United States

Listed under